Biotech Values

[DewDiligence]

Anyone with thoughts on DVAX? Rumors of clinical hold to be removed?

That’s an old rumor that was probably started by posters on message boards—see, for instance, #msg-38217363 and #msg-37493467.

Even if the Heplisav clinical hold were lifted, it would not solve DVAX’s main problem. The FDA found DVAX’s phase-3 data inadequate for approval and it opined that Heplisav was unsuitable for use by the general public: #msg-33018704.

p.s. My own opinion, FWIW, is in #msg-37359751 and #msg-33021823, the latter post being obsolete.